| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 41,324 | 23,252 | 22,400 | 47,070 | | Cost of Revenue | 38,041 | 24,106 | 25,270 | 46,654 | | | Gross Profit | 3,283 | (854) | (2,870) | 416 | | | Operating Expenses | | Research Development | 771 | 748 | 916 | 1,029 | | Selling General and Administrative | 4,277 | 4,682 | 6,372 | 6,831 | | Non Recurring |
-
|
-
|
-
| 55,080 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,765) | (6,284) | (10,158) | (62,524) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,377) | (6,284) | (10,158) | (62,524) | | Interest Expense | (423) | 228 | 195 | 44 | | Income Before Tax | (1,954) | (6,512) | (10,353) | (62,568) | | Income Tax Expense | (536) | 7,551 | (3,313) | (10,352) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,418) | (14,063) | (7,040) | (52,216) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,418) | (14,063) | (7,040) | (52,216) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,418) | ($14,063) | ($7,040) | ($52,216) |
|
0.03% Nasdaq 
0.06 (0.85%) 
Income Statement
